Abstract. Integrin-associated protein (IAP/CD47) is physically associated with the e~v133 vitronectin (Vn) receptor and a functionally and immunologically related integrin on neutrophils (PMN) and monocytes. Anti-IAP antibodies inhibit multiple phagocyte functions, including Arg-Gly-Asp (RGD)-initiated activation of phagocytosis, chemotaxis, and respiratory burst; PMN adhesion to entactin; and PMN transendothelial and transepithelial migration at a step subsequent to tight intercellular adhesion. Anti-lAP antibodies also inhibit binding of Vn-coated particles to many cells expressing av[33. However, prior studies with anti-lAP did not directly address IAP function because they could not distinguish between IAP blockade and antibody-induced signaling effects on cells. To better determine the function of lAP, we have characterized and used an IAPdeficient human cell line. Despite expressing av integrins, these cells do not bind Vn-coated particles unless transfected with IAP expression constructs. Increasing the level of av[33 expression or increasing Vn density on the particle does not overcome the requirement for IAP. All known splice variants of IAP restore Vn particle binding equivalently. Indeed, the membraneanchored IAP Ig variable domain suffices to mediate Vn particle binding in this system, while the multiply membrane-spanning and cytoplasmic domains are dispensable. In all cases, adhesion to a Vn-coated surface and fibronectin particle binding through e~5131 fibronectin receptors are independent of IAP expression. These data demonstrate that some av integrin ligand-binding functions are IAP independent, whereas others require lAP, presumably through direct physical interaction between its Ig domain and the integrin.
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I
NTE6RINS are heterodimeric cell surface receptors that mediate binding to other cells and to ligands in the extracellular matrix. Integrin-dependent ligand binding and clustering-induced signal transduction lead to changes in cell morphology and activation state. Conversely, signals inside the cell can result in changes in integrin ligand affinity and avidity. One of the proteins implicated in these regulatory events is integrin-associated protein (IAP). 1 IAP is a unique Ig family member with an amino-terminal Ig variable (IgV) domain, a multiply membrane-spanning domain, and a short alternatively spliced carboxy-ter-minal cytoplasmic tail (Lindberg et al., 1993; Reinhold et al., 1995) . lAP is identical to OA-3, an ovarian carcinoma antigen, and to CD47, an erythrocyte membrane protein decreased in Rhnun disease (Campbell et al., 1992; Lindberg et al., 1994; Mawby et al., 1994) . Since lAP is ubiquitously expressed (Brown et al., 1990; Rosales et al., 1992; Reinhold et al., 1995) , its function has been inferred from the effect of antibody inhibition, mainly in myeloid and endothelial ceils.
lAP was first identified as the target of antibodies that block extracellular matrix-induced activation of neutrophils (PMN) and monocytes (Brown et al., 1990) . Anti-IAP mAbs also inhibit PMN transendothelial migration, PMN and endothelial cell chemotaxis to RGD-containing proteins, and PMN adhesion to entactin (Cooper et al., 1995; Senior et al., 1992) . In addition, anti-lAP mAbs inhibit an increase in intracellular calcium concentration seen when endothelial cells spread on vitronectin (Vn) in an e~v-dependent manner . These studies all suggest that IAP interacts functionally with the integrin Otv[33, a hypothesis supported by physical association of the two molecules (Brown et al., 1990) . Moreover, anti-IAP mAb inhibits the binding of Vn-coated particles to ~v~3 integrin on a variety of cells in addition to myeloid and endothelial cells (Lindberg et al., 1993) . Studies on the mechanisms by which IAP cooperates with ~v[~3 or by which anti-IAP mAb inhibit various %133 functions have been hampered by the ubiquity of IAP on tissue-culture cells. We have used an IAP-deficient ovarian carcinoma cell line, OV10, to better understand IAPavl33 cooperation. Although adhesion of these cells to a Vn-coated surface is normal, they bind Vn-opsonized beads only if they are made to express lAP by transfection. We show that Vn-bead binding is IAP and integrin dependent and correlates with the level of both integrin and IAP expression. We also demonstrate that the IAP IgV domain is sufficient for this function. As OVI0 adhesion to Vn on a surface is unaffected by expression of IAP, our data demonstrate a clear distinction between two different functions of c~v integrins: binding of Vn-beads, which is IAP dependent, and adhesion to a Vn-coated surface, which is IAP independent.
Materials and Methods

Chemicals, Reagents, and Antibodies
All reagents were of the highest grade commercially available and purchased from Sigma Chemical Co. (St. Louis, MO), unless otherwise indicated. PBS and HBSS were purchased as 10X stocks from Life Technologies/GIBCO BRL (Gaithersburg, MD) or BioWhittaker, Inc. (Walkersville, MD). Negative control mAb 6F2, anti-133 mAb 7G2, and anti-IAP mAbs B6H12 and 2D3 are all mouse IgG1 mAbs and have been described previously (Gresham et al., 1989; Brown et al., 1990) . None of these mAbs bind the corresponding routine antigens. Anti-av mAb L230 (Weinacker et al., 1994) was kindly provided by Dr. Dean Sheppard (University of California at San Francisco), and anti-LIBS1 (Frelinger et al., 1990) was kindly provided by Dr. Mark Ginsberg (The Scripps Research Institute, La Jolla, CA). Control lgGl mAb MOPC21 was from Organon-Teknika (Durham, NC). Anti-J31 mAb P4CI0 (IgGl) and anti-av[3s rnAb P1F6 (IgGl) (Wayner et al., 1991) , as well as rabbit polyclonal anti-human vitronectin receptor, were from Life Technologies/GIBCO BRL. Vn was purchased from Life Technologies/GIBCO BRL and Calbiochem-Novabiochem Corp. (La Jolla, CA). Fluorescinated anti-CD4-IgVt mAb OKT4A was purchased from Ortho Diagnostics (Raritan, NJ).
Tissue Culture
OVM1 and OV10 were maintained in Iscove's modified Dulbecco's medium (IMDM) (Life Technologies/GfBCO BRL) with 10% FCS (Hyclone Laboratories, Logan, UT) and 50 ixg/ml gentamicin. Transfectants based on pRC/RSV or pIAP58 (Invitrogen, San Diego, CA) (Lindberg et al., 1993) were isolated and maintained in 400 txg/ml geneticin/G418 (Life Technologies/GIBCO BRL). Those based on pREP10 (Invitrogen) were selected in 200 Ixg/ml hygromycin (Boehringer Mannheim Biochemicals, Indianapolis, IN); those based on pSRuEN (a kind gift of Andrey Shaw, Washington University, St. Louis, MO) were selected in 800 ixg/ml geneticin. Double transfectants were maintained in medium with 100 Ixg/ml hygromycin and 400 p.g/ml geneticin. For vitronectin bead binding assays, cells were seeded at 20,000 cells per well into glass 8-chambered slides (LabTek; Nunc, Naperville, IL) in 250 Ixl RPMI (BioWhittaker, Inc.) with 10% FCS, 10 mM Hepes, and selective antibiotics at the concentrations stated above.
Flow Cytometry and Cell Sorting
Cells were removed from subconfluent tissue-culture flasks with PBS--2 mM EDTA, washed twice in complete medium, and counted. 1-3 million cells were resuspended in 25 ~l complete medium with 1-3 Ixg antibody (saturating amounts) and incubated on ice for 30 rain. Cells were washed and incubated with 50 ~1 complete medium with 1 ~l goat anti-mouse lgG-FITC (F-7506; Sigma Chemical Co.), and then incubated an additiona130 min. After a wash, cells were analyzed on a flow cytometer (Epics/XL; Coulter Electronics, Inc., Hialeah, FL). For cell sorting, 15 million cells were stained with proportionately larger amounts of medium and antibody, resuspended at 5 million cells per ml, and sorted on a fluorescenceactivated cell sorter (Epics 743; Coulter Electronics, Inc.).
Selection of an IAP-deficient Cell Line
The ovarian carcinoma line OVM1, kindly provided by Dr. Stimson (Strathclyde University, Glasgow, UK), was described as CD47 deficient by Campbell et al. (1992) . The cells we obtained contained a small proportion (0.5-1%) of IAP-positive cells. Therefore, we cloned this cell line and selected numerous IAP-deficient clones from it. After tests of transfectability, the clone OVl0 was chosen for further study. OV10 is IAP deficient by FACS ® and immunoprecipitation with all our IAP mAbs, negative by immunoprecipitation with polyclonal rabbit anti-IAP carboxy-terminal peptide antisera (Lindberg ct al., 1993) , and negative for IAP mRNA by Northern blot and reverse-transcriptase PCR assays (not shown). We have been unable to detect spontaneous lAP-positive cells in OV10 populations. OVI0 express a small amount of avl33, a moderate amount of av!35 (Table I) , and a large amount of %131 (not shown).
IAP Expression Constructs and Transfectants
IAP alternative splice variants are referred to as IAP-1 through IAP-4 in order of increasing cytoplasmic tail length (Reinhold et al., 1995) . The pRC/RSV-based vector pIAP58 and the plAP58-derived expression constructs plAP45 (IAP-2), plAP71 (IAP-1), and pIAP83 (mIAP; murine IAP-2) have been described previously (Lindberg et al., 1993) . The IAP-4 expression construct pIAP120 was constructed in analogy with plAP71, except that the 3'-portion of the cDNA was derived from an IAP-4 clone. The 3'-fragment of the IAP-3 expression construct pIAP131 was constructed from the IAP-4 version by PCR-mediated deletion of the 3'-end of the coding sequence, to correspond to the published IAP-3 sequence (Lindberg et al., 1993; Campbell et al., 1992; Reinhold et al., 1995) . The IAP coding sequence of all constructs has been verified by dideoxynucleotide chain-termination sequencing (Sanger et al., 1977) . The constructs were transfected into OV10 using the lipofectin method (Life Technologies/GIBCO BRL). Clones were isolated by limiting dilution 24 h after transfection. Several clones of the vector and IAP-2 transfectants were assayed with similar results. In some cases, clones were FACS ® sorted to remove populations of lower expression. The clones presented in this study are 58A2 (vector), 71E3 (lAP-I), 45B10 (lAP-2), 131G7 (IAP-3), 120B9 (IAP-4), and 83E7 (mlAP).
The IAP-glycosylphosphatidylinositol (GPI) construct plAP148 was constructed by cloning the lAP 5'-end up to and including the IgV domain as a XbaI-PvulI fragment and a PvuII-HindllI fragment encoding the human decay-accelerating factor (DAF) GPI signal (Medof et al., 1987) (kindly provided by Dr. Douglas Lublin, Washington University, St. Louis, MO) into XbaI-HindlIl-digested plAP58 vector. The fragment encoding the GPI signal was generated by PCR using the following oligonucleotides: AACCCTGCAGCTGGCATGAAACAACCCCA and CAATGAAAGCTrCCTAAATGAAGAG. Conversely, the sequence coding for the IAP-2 membrane and cytoplasmic domains was isolated from plAP70 (Lindberg et al., 1993) and fused with a PCR-generated HindlllPvulI fragment of the 5'-end of human CD4 (kindly provided by Dr. Andrey Shaw) up to and including the first IgV domain, yielding the plasmid plAP147. The oligonucleotides used were: TGGTCTAGATGTCCCT-ACTGCTCAGCC and GTCAATCCGCTGCAGCTGAATTGCACCTC-CTC. Transfectant clones were generated as described above. The clones used in this study were 148A10T (IAP-GPI) and 147E9 (CD4-1AP). To verify results obtained with IAP-GPI, two additional independent transfectants (148C11 and 148D12) were analyzed.
For higher IAP expression, the insert from plAP45 (IAP-2) was cloned as an XhoI-XbaI fragment into the monocistronic vector pBSRtxEN (kindly provided by Dr. Andrey Shaw), yielding plAP315. Also, a construct encoding the IAP-IgV domain linked to a single membrane-spanning segment was made in the following manner: oligonucleotides CCTGGG-CCACCAGCTGACTAA from plAP3 [Lindberg et al., 1993] ) and cloned into pBSRc~EN, yielding pIAP323. In both cases, a single round of FACS ® sorting yielded a population with high expression in a narrow distribution. These populations were designated IAP-2(hi) (plAP315) and IAP-TM (plAP323).
To obtain OV10 transfectants with increased expression of integrin Otv[~3, a ~3 expression plasmid was constructed by ligating the human integrin 133 cDNA as an Xbal fragment into NheI-digested pREP10 (Invitrogen), yielding pIAP164. Transfecting this construct into OV10 with or without a 20-fold excess of pCDM8-av (Loftus et al., 1990) , and selecting for hygromycin resistance, resulted in equivalent average levels of av133 expression with a corresponding increase in surface expression of C~v (as assayed by FACS ® with mAbs AP3 and L230; Table I ). This suggests that 13 chain synthesis limits av133 expression. One clone of pIAP164-transfected OV10 (OV10/164-10) was chosen and transfected in a second step with previously described IAP constructs, followed by geneticin selection and cloning. The transfectant clones used are: 133/vector (pIAP164+ plAP58B3), 133/IAP-2 (plAP164+45S2), and 133/IAP-GPI (plAP164+ plAP148C2), to yield cells expressing high amounts of ctv~3 without lAP, with wild-type IAP, or with the lAP IgV domain on a GPI anchor, respectively.
Bead Binding
Confluent monolayers of OV10 transfectants were removed with trypsin-EDTA, washed in complete medium, and resuspended at 20,000 cells per ml in RPMI-based selection media (RPMI with 10% FCS, 400 p,g/ml G418, and/or 100 ~xg/ml hygromycin, depending on the transfectant). Cell suspensions were added to glass 8-chamber LabTek slides and cultured for 24 h at 37°C in 5% CO2. Vn-bead binding was optimal in a buffer of HBSS containing 10 mM Hepes, 0. 1 mM MnCI2, and 1% human serum albumin (HSA) (bead-binding buffer), which was used for all studies. Adherent cells were washed twice with buffer and incubated with antibodies in 250 Ixl buffer for 20 min at room temperature. The antibodies used were MOPC21, anti-lAP mAb 2D3 and B6H12 (Brown et al., 1990) , anti-133 mAb 7G2 (Gresham et al., 1989; Brown et al., 1990) , and anti-C~v135 mAb P1F6 (Wayner et al., 1991) all at 10 Ixg per well, as well as anti-131 P4CI0 (1:50 dilution of ascites). After incubation with the antibodies, the adherent cells were washed twice, and 250 Ixl buffer was added to each well. Vnand HSA-coated beads were made exactly as described (Lindberg et al., 1993) , except that the source of the Vn was Life Technologies/GIBCO BRL or Calbiochem-Novabiochem Corp. The cells were incubated with either 20 Ixl Vn-or HSA-coated beads. For 133 transfectants in Fig. 5 , A and C, the volume of beads was reduced to 5 ixl to facilitate counting of attached beads. After 1 h at 37°C, unbound beads were washed away, and the number of beads bound was assessed by fluorescence microscopy. Binding was quantitated as an attachment index, the number of beads bound per 100 cells.
Assay for Ligand-induced Binding Sites
OV10 transfectants were harvested in PBS-2 mM EDTA, washed twice in HBSS without divalent cations, and resuspended to 2 million cells per ml in bead-binding buffer or in bead-binding buffer with 5 mM MgC12 rather than 0. 1 mM MnCl 2, Human IgG (500 i.Lg/ml) was used to further reduce nonspecific binding. 100-~1 aliquots were incubated 30 min at room temperature with anti-LIBS1 (10 Iz/ml) (Frelinger et al., 1990 ) and KYAVT-GRGDS at varying concentrations. After two washes, cells were stained with FITC-labeled secondary antibody and analyzed by flow cytometry.
Adhesion Assays
Flat-bottom 96-well microtiter plates (Immulon2; Dynatech Laboratories, Inc., Chantilly, VA) were coated overnight (4°C) with matrix protein in PBS, blocked for 1 h or more with PBS/1% HSA at room temperature, and washed twice with HBSS without divalent cations (HBSS--) before cell addition. Subconfluent monolayers were removed with PBS/5 mM EDTA twice in IMDM (without FCS) and incubated at 3 million cells per ml for 15 min (37°C) in IMDM-1% BSA containing 3 p.M calcein-AM (Molecular Probes, Eugene, OR). Ceils were washed twice in HBSS--, followed by resuspension in bead-binding buffer (HBSS/0. 1 mM MnCIJ1% HSA) at 1 million cells per ml. Cells were diluted 1:2 in buffer containing the appropriate blocking mAb, preincubated for 10 min at room temperature, and added to the microtiter plates at 100 ~1 per well (50,000 cells). After 60 rain at 37°C, fluorescence was read on a plate reader (excitation 485 rim, emission 530 nm; Cytofluor 2300; Millipore Corp., Bedford, MA) before and after two washes with adhesion buffer. Data are given as the fraction of total fluorescence that was retained through the washes.
Maximal adhesion obtained with any substrate was ~80%, with background from blocked wells <2%.
Phosphoinositide Phospholipase C Treatment
Confluent monolayers of cells were removed with trypsin-EDTA, washed in complete IMDM with 10 mM EDTA, and resuspended in the same medium to 3 million cells per ml. 0.5-ml aliquots were incubated with or without the addition of 0.1 U of phosphoinositide phospholipase C (PI-PLC) (Boehringer Mannheim Biochemicals) for 1 h at 37°C. Volumes of 0.1 ml were pelleted in microtiter plates, washed, and processed for flow cytometry after staining with negative control mAb 6F2 or anti-IAP mAbs 2D3 or 1F7. Both anti-IAP mAbs gave identical results.
IAP-fl3 Coimmunoprecipitation
Cells were grown to subconfluence, harvested by scraping, and washed three times in HBSS--. 40 million cells (routinely >98% intact by trypan blue exclusion) were lysed in 1 ml 0.25 M sucrose/50 mM Hepes (pH 7.4)/ 100 mM octylglucoside with protease inhibitors (5 mM iodoacetamide, 1 mM PMSF, 50 Ixg/ml aprotinin, 50 p,g/ml leupeptin) by rotation for 2 h at 4°C. Lysates were cleared by a 30-min centrifugation (15,000 g) at 4°C. Equal fractions of the lysate were rotated at 4°C with 50 pA anti-IAP (2D3), anti-133 (7G2), or anti-err135 (P1F6) Sepharose. Sepharose was prepared by binding 2 mg mAb to 1 ml cyanogen bromide-activated Sepharose (Pharmacia, Uppsala, Sweden) as recommended by the manufacturer. The affinity Sepharose was washed with 10 mM Tris-HC1 (pH 8.0)/0.1% Tween-20 and 150 mM NaCI. Bound protein was eluted by incubation for 10 min at 65°C with nonreducing SDS sample buffer (Laemmli, 1970) . Equivalent fractions of the total sample were electophoresed on 7.5% SDS-PAGE, transferred to Immobilon P (Millipore Corp.), and reacted with anti-133 mAb 7G2. Detection was by enhanced chemiluminesence according to the manufacturer's recommendations (ECL; Amersham Corp., Arlington Heights, IL).
Results
Vn-Bead Binding Is Deficient in OVIO, But Can Be Restored by lAP Transfection
To analyze the structure-function relationships in IAP, we isolated an IAP-deficient clone, OV10, from the ovarian carcinoma cell line OVM1 (see Materials and Methods).
OV10 cells express large amounts of [~1 and et5 (not shown), a moderate amount of etv and 135, and a small amount of [33 (Table I) . When assayed for Vn-bead binding, OV10 cells showed attachment indices only marginally above those seen with beads coated with HSA. However, transfectants expressing IAP-2 (Fig. 1) , the predominant form of IAP in myeloid cells, showed a markedly enhanced capacity to bind Vn-beads (Fig. 2 A) . Binding was increased with increasing Vn density on the bead, but it remained IAP dependent up to saturating Vn concentrations (~12.5 ~g/ ml). The IAP-mediated enhancement of Vn-bead binding was completely reversed by the functional anti-IAP mAb B6H12 (Fig. 2 A) . The IAP dependence was Vn specific, as binding to fibronectin (Fn)-opsonized beads was independent of IAP and unaffected by the presence of antilAP mAb B6H12 (Fig. 2 B) . Vn-bead binding was entirely dependent on Ctv[33 and Ctv135, as shown by its sensitivity to anti-133 mAb 7G2 (Fig. 2 D) and anti-ctv[35 mAb P1F6 (Fig.   2 C) , and was independent of [~1 integrins, as shown by resistance to inhibition by anti-131 mAb P4C10 (Fig. 2 C) . In contrast, Fn-bead binding was almost completely inhibited by P4C10, but unaffected by 7G2 (Fig. 2 B) . Anti-IAP mAb 2D3 binds lAP with similar affinity as B6H12, but it has been shown to be nonfunctional in assays of Vn-bead binding and other IAP-dependent integrin functions (Lindberg et al., 1993) . This was also true in our transfection system, where mAb 2D3 did not inhibit Vn-bead binding of IAP transfectants (Fig. 2 D) . Vn-bead binding was also high in OV10 expressing murine IAP, showing that the IAP effect on integrin function is not species specific (Fig. 2 E) . This result also verified that the effect of anti-IAP mAb B6H12 is specific, since this mAb has no effect on Vn-bead binding by the murine IAP expressors. IAP function has been associated with C~v[33 rather than av[35. To determine if this was true in OV10, we tested the effect of anti-C~v[35 mAb P1F6 on Vn-and Fn-bead binding. P1F6 completely inhibited Vn-bead binding in a manner similar to anti-J33 mAb 7G2 (Fig. 2 C) . Surprisingly, testing multiple preparations from several sources, we consistently found inhibition of Fn-bead binding by P1F6 as well (Fig. 2 B) . This suggests that P1F6 ligation of C~v[35 may affect the function of multiple OV10 integrins, perhaps through "integrin cross talk" (Blystone et al., 1994 (Blystone et al., , 1995 . Thus, our data indicate that expression of IAP specifically and markedly enhances Vn-bead binding, but we cannot determine the relative contributions of C~v[33 and av[35.
Adhesion to a Vn-coated Surface Is lAP Independent
To investigate the role of IAP in adhesion to a Vn-coated surface, we adhered different transfectants to microtiter plate wells coated with different concentrations of Vn (1 ng/ml to 10 ~g/ml) for 60 rain, using the same conditions as for the Vn-bead binding. Adhesion was maximal at a coating concentration of 100 ng/ml Vn, and only marginally above background at 3 ng/ml (not shown). Anti-J33 7G2 does not inhibit adhesion in other clearly ~XvJ33-dependent systems, and it failed to do so here as well. Therefore, anti-c~ v mAb L230 was used in combination with anti-%J35 mAb P1F6 to dissect integrin dependence. At a Vn concentration of 50 ng/ml, binding was inhibited completely by L230 and almost completely by P1F6. Only minimal differences in binding between IAP-positive and lAP-negative cells were seen (Fig. 3) , which correlated with small differences in C~vf33 and ~vJ35 expression (Table I) . OV10 expressing high levels of [33 from transfected 133 cDNA (J33/vector and ~3/IAP-2) maintained significant binding in the presence of 10 ~g/ml anti-%J35 mAb PIF6. This suggests that binding under these conditions was mainly Uv~5 mediated in the low 133 cells (vector and IAP-2) and mediated by both ct v integrins in the high 133 expressors. Both in the presence and absence of P1F6, there was no effect of anti-lAP B6H12 even at 150 p~g/ml ( Fig. 3 ; not shown). Thus, under these conditions, lAP is uninvolved either in J3~ integrindependent binding of particles coated with Fn or in adhesion to a Vn-coated surface.
The lAP Cytoplasmic Domain Is Irrelevant for Vn-Bead Binding
IAP exists as four different forms generated by alternative splicing that differ only in their carboxy-terminal cytoplasmic extensions. These forms are called IAP-1, IAP-2, IAP-3, and IAP-4 (Fig. 1) , in order of increasing cytoplasmic tail length (Reinhold et al., 1995 , or underlined letters (sequences derived from CD4, CD7, or created in the fusion). The GPI anchor is shown as a circle connected to the serine residue to which the GPI anchor is linked. Residues shown within parentheses are removed as the GPI anchor is added, lAP-l, IAP-2, IAP-3, and IAP-4 correspond to naturally occurring splice variants of lAP. The expression of the correct tail has been verified for forms to which specific antisera have been raised (IAP-2 and IAP-4). IAP-2 and IAP-2(hi) differ only in the level of expression and the expression vector used. Murine lAP (mlAP) has the murine IAP-2 tail (not shown).
expressed, the alternative splicing is u n d e r strict cell t y p especific control, leading to the almost exclusive expression of I A P -2 in myeloid cells and endothelium, and virtually exclusive expression of I A P -4 in n e u r o n a l tissue (Reinhold et al., 1995) . T o d e t e r m i n e the role of the l A P cytoplasmic tail in V n -b e a d binding, we used transfectants expressing the different splice forms of I A P in the bead binding assay. A s shown in Fig. 2 , C and D, expression of any of the four forms of l A P in O V 1 0 led to e n h a n c e m e n t of V n -b e a d binding. This included IAP-1, which has only plate wells coated with Vn (50 ng/ml) in the presence or absence of various mAbs (B6H12 and 2D3 at 150 ~g/ml, L230 and P1F6 at 40 txg/ml). Maximal adhesion was 70-80%, and background was 0-2%. Means + SEM for triplicate wells from a representative experiment are shown. Experiments varying the Vn-coating concentration (1 ng/ml to 10 ixg/ml) or incubation time (15-120 min), or the anti-lAP concentration (10 txg/ml to 150 ixg/ml), failed to show any effect of lAP on the level of adhesion.
four amino acids after the last hydrophobic membrane segment (Lindberg et al., 1993) . Thus, the 13-, 20-, and 32-amino acid cytoplasmic segments of IAP-2, -3, and -4 are neither necessary nor inhibitory for the lAP-dependent Vn-bead binding phenotype.
The lAP IgV Domain on a GPI Anchor Is Sufficient to Mediate the lAP Effect on Vn-Bead Binding
We next sought to determine the roles for the IAP extracellular and multiply membrane-spanning domains in Vnbead binding. For this purpose, we made a construct encoding the I A P IgV domain fused to the h u m a n D A F GPI anchor signal ( I A P -G P I ) , as well as the "inverse" construct encoding the h u m a n CD4 IgV1 domain fused to the IAP-2 m e m b r a n e and cytoplasmic domains ( C D 4 -I A P ) (Fig. 1) . Clones of the corresponding transfectants expressed the recombinant proteins (Table I) . Surprisingly, I A P -G P I enhanced Vn-bead binding, while C D 4 -I A P failed do so (Fig. 4 A) . To confirm this unexpected finding, two additional transfectant clones of I A P -G P I were tested 148Cll, 148D12) and a control clone expressing IAP-2 were trypsinized and incubated for 1 h at 37°C in complete medium with 2 mM EDTA with or without 0. 2 U/ml PI-PLC, as described in Materials and Methods. After the digestion, cells were washed and stained with anti-IAP mAb 2D3 (no PI-PLC and 2 U/ml PI-PLC) followed by FITC-goat anti-mouse IgG and analysis by flow cytometry. As a negative control, untreated cells were stained with mAb 6F2 (control mAb). PI-PLCtreated cells gave identical reactivity with the control mAb and are therefore not shown. The PI-PLC treatment completely removed surface lAP reactivity from the IAP°GPI clones, whereas it had no effect on wild-type lAP, showing that the clones indeed expressed the expected IAP form (representative of two experiments). Data obtained using anti-IAP mAb 1F7 were identical (not shown).
for Vn-bead binding, yielding similar results (Fig. 4 B) . Furthermore, we confirmed that I A P -G P I was in fact GPI linked by demonstrating that essentially all anti-lAP reactivity could be removed from the surface of I A P -G P I by PI-PLC, whereas expression of wild-type IAP-2 was unaffected by this enzyme (Fig. 4 C) . Thus, the GPI-anchored I A P IgV domain is sufficient for the restoration of Vnbead binding to IAP-deficient cells.
The lAP IgV Domain Functions Irrespective of the Nature of the Domain Anchoring It to the Membrane
GPI-anchored proteins exist in specialized membrane domains in which they are associated with intracellular src kinases (Brown, 1993) . Cross-linking of several GPI-linked proteins leads to kinase activation (Brown, 1993) . It is therefore theoretically possible that the I A P multiply membrane-spanning domain functions in a manner that can be duplicated by these special properties of the GPI anchor. To exclude this possibility, we generated cells expressing the IAP-IgV domain linked to the single transmembrane segment of human CD7 ( I A P -T M ) (Fig. 1 ). As shown in Fig. 5 A, this construct enhanced Vn-bead binding as well as IAP-2 and I A P -G P I , showing that the membrane-anchored IAP-IgV domain suffices for this phenotype, irrespective of the exact nature of the membrane anchor.
Increases in Either lAP or avfl3 Expression Lead to Increased Vn-Bead Binding
We observed that the extent of Vn-bead binding correlated with the level of I A P expression regardless of splice form. This suggested that I A P expression was limiting to Vn-bead binding. To test this hypothesis, we made a construct encoding IAP-2 using a more efficient promoter (see Materials and Methods). A transfectant of this construct (IAP-2[hi]) expressed I A P at significantly higher levels than the control clone (IAP-2) ( Table I ) and bound Vn-beads at a significantly higher level than the IAP-2 construct (attachment index of 373 vs 181) (Fig. 5 B) . Thus, the extent of bead binding correlated with I A P expression. It was surprising that Vn-bead binding was inhibited by anti-[33 m A b 7G2, even though OV10 expresses only minimal levels of integrin ad33 (Table I) . To investigate this further, and to test the hypothesis that l A P dependence could be overcome by increased surface expression of the integrin, we derived a series of clones with high e~v133 expression by transfection with [33-encoding constructs (Materials and Methods). Even with high expression of the a~63, Vn-bead binding was markedly enhanced by I A P (Fig. 5 C) . Clones overexpressing both the integrin and I A P (13JIAP-2) bound Vn-beads to a much greater extent than even the 1AP-2(hi) clone (Fig. 5 B) , although they had significantly lower l A P surface expression than 1AP-2(hi) (3.77 +-0.13 vs 36.93 +_ 0.81; see Table I ). Thus, both C~v[33 expression and l A P expression are limiting for Vnbead binding by OV10. In the av63-overexpressing clones, the membrane-anchored I A P IgV domain alone was still sufficient to restore Vn-bead binding, since expression of I A P -G P I was as efficient as IAP-2 (Fig. 5 C; lower attachment indices in this experiment reflect the lower bead con- in the presence of 40 ixg/ml anti-133 mAb 7G2 were 9, 11, 13, and 22, respectively, and those obtained with HSA beads were 1, 2, 1, and 5, respectively. Increases in lAP expression increased Vnbead binding, as did increased a~133 expression. (C) A transfectant expressing high levels of c~133 was generated and retransfected with vector alone (fl3/vector), o r expression constructs for
IAP-2 ([33/IAP-2) or IAP-GPI ([33/IAP-GPI).
In the presence of 40 I~g/ml 7G2, attachment indices were 2, 5, and 5, respectively. With HSA beads, they were ~<2. As all these Otv~ 3 overexpressors showed markedly enhanced binding (see B), fewer beads were used in the assay, to arrive at countable levels of Vn-bead binding (see Materials and Methods). Despite the higher level of o~v[3 3 expression, Vn-bead binding is still IAP dependent and can be mediated by the GPI-anchored IAP-IgV domain.
centrations used in this experiment). As with the original OV10 l A P transfectants, the enhancement of Vn-bead binding in the etv133-overexpressing cells was completely reversed by anti-lAP m A b B6H12 and completely inhibited by anti-J33 m A b 7G2. Despite overexpression of o~vl33, anti-av135 m A b PIF6 also completely inhibited Vn-bead binding (Fig. 6) .
Induction of f13 Ligand-induced Binding Sites Is Not Influenced by lAP
To determine if I A P alters the affinity state of e~v133, we determined the generation of the ligand-induced [33 LIBS1 epitope by increasing concentration of peptide KYAVT-G R G D S on OV10 expressing high amounts of av133 with or without IAP-2 (see Materials and Methods). Over a range of 1-1,000 txM ligand, there was clear induction of the LIBS1 epitope, with a higher ligand sensitivity in 0.1 mM MnCI2 than in 5 mM MgC12. However, we observed no difference between IAP-positive and IAP-negative cells in these experiments (not shown).
Coimmunoprecipitation of [33 and lAP
The dependence of Vn-bead binding on the plasma membrane concentration of both I A P and Ctv133 suggested that the relevant binding structure contained both molecules, as has been shown previously (Brown et al., 1990; Zhou and Brown, 1993) . Thus, we examined whether the two proteins could be coprecipitated in transfected OV10 cells. When either IAP-2 or I A P -G P I was immunoprecipitated, coprecipitated [33 could be detected by Western blotting (Fig. 7) , showing that the Ctv133 association can be mediated by the I A P IgV domain alone. No 133 was coprecipitated with Ctv135. Coprecipitated 133 was a small minority of total Cell extracts in 100 mM octyl-glucoside were prepared from transfectants overexpressing etv133 and IAP-2 (lanes 1, 4, and 7), av133 alone, (lanes 2, 5, and 8), or av133 and IAP-GPI (lanes 3, 6, and 9) and immunoprecipitated with anti-ctv [35 mAb P1F6, antilAP mAb 2D3, Immunoprecipitates were separated by nonreducing SDS-PAGE, transferred to Immobilon P, and immunoblotted with anti-133 mAb 7G2. Peroxidase-conjugated anti-mouse IgG was used as a secondary antibody, followed by detection with enhanced chemiluminesence. A reactive band migrating at the 133 position (~95 kD) can be seen in both the IAP-2 and IAP-GPI transfectants (lanes 4 and 6), but is absent in the IAP-deficient control (lane 5). No 133 was coprecipitated with the control antibody P1F6, whereas anti-133 mAb 7G2 could immmunoprecipitate the antigen from all three cell types. Thus, both IAP variants associate with 133 integrin.
133, suggesting that the majority of both l A P and 0tv133 was not in a stable complex.
Discussion
Antibody to integrin-associated protein (IAP/CD47) has been shown to affect a large number of cell functions associated with Uv133 and ~v133-1ike integrins, such as Vn-bead binding, R G D activation of Fc-receptor-mediated phagocytosis, chemotaxis, and oxidative burst, as well as PMN migration through epithelial or endothelial barriers (Parkos et al., 1991 (Parkos et al., , 1996 Cooper et al., 1995; Gresham et al., 1992; Senior et al., 1992) . Because of the ubiquity of I A P expression, it has been difficult to determine if the effects of anti-lAP m A b were to inhibit I A P function, or if m A b binding to l A P generated a negative signal that then inhibited function. Indeed, the transfection of human I A P into C H O cells expressing hamster l A P made Vn-bead binding sensitive to the anti-human I A P m A b B6H12, raising the possibility that the antibody generated a signal that specifically regulated ot v integrin function (Lindberg et al., 1993) . In this paper, we have directly tested whether or not l A P is necessary for Vn-bead binding by Otv integrins. We have shown that a cell line lacking I A P fails to bind Vn-beads and that expression of l A P on these cells confers the ability to bind Vn-coated particles. Increased integrin expression led to increased binding, but failed to obviate the l A P requirement. Thus, the phenotype of IAP-deficient cells is similar to that of anti-lAP-treated, IAP-expressing cells. The requirement for I A P does not reflect direct binding of Vn-beads by IAP, since in all cases it is inhibited completely by anti-133 and Ctv135 mAbs. Expression of l A P does not influence 131 integrin bead binding, since ~513a integrinmediated binding of Fn-beads is unaffected by the absence of IAP.
In requiring IAP, Vn-bead binding differs from adhesion to a Vn-coated surface, which is l A P independent. Similarly, txv-dependent spreading of endothelial cells on Vn is I A P independent, whereas the concomitant rise in intracellular calcium concentration can be inhibited by anti-lAP mAbs . A difference in Fnbead binding and adhesion to a Fn-coated surface has been described for K562 cells, which was attributed to the requirement for a high affinity %131 in Fn-bead binding (Blystone et al., 1994) . Possibly, lAP is necessary for a higher avidity of avl33, which might be required for Vnbead binding. Whether this reflects a dependence on IAP for generation of high affinity e%133 or another mechanism for creating increased avidity, such as receptor clustering or altered receptor interaction with the cytoskeleton, is unclear. However, while RGD peptide induced the activation-dependent LIBS1 epitope on etv133-overexpressing OV10, this was independent of IAP expression. Whatever the mechanism, these studies clearly demonstrate an important distinction between bead binding and adhesion. Thus, studies using bead binding as a model for adhesion to a surface (Miyamoto et al., 1995a,b) need to be interpreted with some caution.
The extent of Vn-bead binding is dependent on the levels of both lAP and av133 expression, but even increasing c~133 expression 10-fold did not make bead binding lAP independent. Previous work in K562 cells has shown that Vn-bead binding also requires expression of % integrins (Blystone et al., 1994) . Since Vn-bead binding is sensitive to the concentrations of both lAP and ~[33 in the cell membrane, it is likely that bead binding requires a physical complex between IAP and the integrin. As previously shown for platelets (Brown et al., 1990) , integrin 133 coimmunoprecipitates with lAP in OV10 transfectants. However, under the conditions of the assay, most lAP on the cell surface is not associated with 133 integrin, and most etv[33 is not associated with lAP. Using the mild detergent conditions required to show coprecipitation, lAP is relatively poorly solubilized, whereas harsher conditions disrupt IAP-integrin association. It is clear, since lAP can be expressed on ceils in the absence of a~ integrins (Blystone et al., 1994) , and o~v integrins can be expressed without lAP in OV10, that transport to the plasma membrane does not require complex formation between these proteins. Instead, the complex probably forms on the plasma membrane, presumably in equilibrium with free IAP and e~v133. The complex has ligand-binding properties distinct from free av[33. A simple explanation for the requirement of IAP in % integrin bead binding would be that IAP is necessary for generation of the high affinity form of the integrin. However, we found no evidence for any IAP-dependent change in ligand affinity, using the display of the LIBS1 epitope as assay. This does not rule out the possibility that a small but functionally important subset of C~v integrin molecules are affinity regulated by lAP, but it is more likely that lAP acts in some other way to alter the function of C~v integrins. It will be interesting and important to determine which of the integrin's functions in migration, neovascularization, metastasis, etc. (Leavesley et al., 1992 (Leavesley et al., , 1993 Brooks et al., 1994; Filardo et al., 1995) are actually dependent on its association with lAP.
OV10 cells express much more C~vl35 than av133 (Table 1) . Since Vn-bead binding is dependent on IAP, and on K562 cells (which express lAP), etv135 can bind Vn-beads in the absence of c~133 (Blystone et al., 1994) , it is very likely that av135 also interacts functionally with lAP. We could not coimmunoprecipitate lAP with c~135, but this may reflect only a slightly lower interaction between the two molecules in detergent solution than between lAP and etvl33. Both anti-J33 mAb 7G2 and anti-etv[35 mAb P1F6 completely inhibit Vn-bead binding regardless of the relative amounts of av133 and av[35. Furthermore, P1F6 but not 7G2 blocked Fn-bead binding. In contrast, P1F6 had no effect on adhesion to Vn (Fig. 3) or Fn (not shown). While the basis of these effects of av integrin antibodies on bead binding is unknown, they may reflect interintegrin signaling (cross talk) (Blystone et al., 1994 (Blystone et al., , 1995 . Alternatively, inhibition may reflect clustering of several integrins at sites of cell-bead contact, with resulting steric inhibition of binding by either mAb. However, lAP would reasonably be expected to be present in such an aggregate, and a purely sterical inhibition is hard to reconcile with the lack of effect of the noninhibitory anti-lAP mAb 2D3.
The absence of IAP in OV10 cells allowed the first structure-function studies on IAP. These studies demonstrated that the amino-terminal IgV domain was necessary and sufficient for Vn-bead binding. The importance of the IgV domain of lAP for interaction with etv integrins is intriguing because interactions between Ig family members and integrins are well-described mechanisms for cell-cell interaction in the immune system. ICAM-1 interaction with 132 integrins (Diamond et al., 1991; Staunton et al., 1990) , PECAM-1 with C~v133 (Piali et al., 1995; Buckley et al., 1996) , VCAM-1 with a4131 (Elices et al., 1990) , and Mad-CAM with 0t4137 (Berlin et al., 1993; Briskin et al., 1996) all have roles in transendothelial migration of leukocytes. In contrast to these cell-cell adhesive interactions, the IAPintegrin interaction must involve an IgV domain on the same cell as the integrin, lAP interaction with % integrins would represent an extension of the paradigm of Ig family-integrin binding to interactions between molecules on a single plasma membrane.
The cell type-specific expression of different cytoplasmic tail forms of lAP would suggest that this part of the molecule has a specific functional role. Also, the anti-lAP inhibitable inward calcium flux in endothelial cells spreading on Vn makes the IAP multiply membrane-spanning domain a potential candidate for a channel. Surprisingly, both these parts of the lAP molecule are dispensable for Vn-bead binding in our transfection system. It is theoretically possible that a mutated form of lAP is expressed by OV10 and is able to interact with IAP-GPI and IAP-TM, reconstituting a functional but noncovalently associated lAP molecule. However, we have been unable to detect in OV10 any lAP message by reverse transcriptase-PCR, any IAP-2 or IAP-4 cytoplasmic tail by immunoblot or immunoprecipitation with specific antisera, or any IAP Ig immunoglobulin domain with monoclonal and polyclonal anti-lAP antibodies by immunoprecipitation or FACS ® (not shown). This makes the existence of any mutant lAP protein in OV10 highly unlikely. More likely, while interaction with % integrins is mediated by the IgV domain, other, as yet undefined functions of lAP require these other domains.
Recently, lAP has been shown to be the receptor for the carboxy-terminal cell-binding domain of thrombospondin-1 (TS-1) (Gao et al., 1996) . TS-1 is a 450-kD trimeric matrix protein that, in addition to the cell-binding domain, has several other cell-and matrix-interaction domains, includ-ing a RGD sequence capable of ligating C~vl33. This suggests the possibility that the Vn used may contain small amounts of TS-1, and that this contaminant is responsible for the lAP effect on Vn-bead binding. However, binding of beads coated with synthetic RGD peptides and analogs is also inhibited by anti-lAP (Gresham et al., 1989 Brown et al., 1990) , ruling out the possibility that TS-1 contamination of Vn is the reason for the IAP dependence.
In summary, this work is the first to show that any specific function of av requires lAP. Surprisingly, Vn-bead binding by tXv integrins, which is IAP dependent in OV10 cells, requires only a membrane-associated IAP IgV domain, and the IgV domain is sufficient to mediate coimmunoprecipitation of IAP with etv~ 3. This suggests that the IAP--avl33 complex represents an extension of the integrin-Ig family adhesive interactions to molecules on a single plasma membrane for the purpose of modulating integrin function. The structural details and biological consequences of this modulation, as well as the functions of the more complex membrane-spanning and cytoplasmic domains of lAP, remain to be determined.
